Volume 77, Number 5, August 2, 2011
About this course
- Released: 08/01/2011
- Expires: 08/02/2013
Upon completion of the article by Escolar et al, the participant should be able to:
• State the doses of prednisone used in the weekend-only and daily treatment arms of this study
• State the primary outcome measure and the primary safety endpoint of this study
• Discuss the findings from this study comparing the efficacy and safety of weekend versus daily prednisone in Duchenne muscular dystrophy (DMD)
The article by Escolar et al covers the following core competency:
• Medical Knowledge
Upon completion of the article by Singer et al, the participant should be able to:
• Discuss the differential diagnosis of a patient with evidence for an autonomic neuropathy
• State the clinical findings and laboratory features of autoimmune autonomic ganglionopathy
• State the clinical features, etiologic investigation, and laboratory findings of amyloid neuropathy
The article by Singer et al covers the following core competencies:
• Medical Knowledge
• Patient Care
Refer to listing above the references in each article.
THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MISSION STATEMENT/PROGRAM OBJECTIVES
After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.
The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
Steven Lewis, MD, has received personal compensation in an editorial capacity for the National Board of Medical Examiners and the American College of Physicians; Paul Schulz, MD, has received personal compensation for activities with Pfizer.
This CME program receives no commercial support.